{"pmid":32241762,"title":"Covid-19: Can France's ethical support units help doctors make challenging decisions?","text":["Covid-19: Can France's ethical support units help doctors make challenging decisions?","BMJ","Arie, Sophie","32241762"],"journal":"BMJ","authors":["Arie, Sophie"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241762","week":"202014|Mar 30 - Apr 05","doi":"10.1136/bmj.m1291","source":"PubMed","locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"weight":0,"_version_":1663079112882782210,"score":7.6048946,"similar":[{"pmid":32241695,"title":"SARS-CoV-2 outbreak: How can pharmacists help?","text":["SARS-CoV-2 outbreak: How can pharmacists help?","Coronaviruses (CoVs) are a large family of viruses that cause disorders ranging from a mild cold to severe disease. Some of the CoVs are zoonotic, meaning they can be transmitted from animals to humans. In December 2019, the world awoke to a new zoonotic strain of CoV that was named SARS-CoV-2 (standing for severe acute respiratory syndrome coronavirus 2), which has been classified as a high-consequence infectious disease. In addition, serious complications related to COVID-19 have been reported in some patients. These include acute respiratory distress syndrome, acute renal failure, septic shock and ventilator-associated pneumonia. The pharmacist, as a healthcare practitioner, can play an important role in hindering the spread of COVID-19, and can be an active participant in national and community efforts to fight and contain this outbreak.","Res Social Adm Pharm","Al-Quteimat, Osama M MSc, BCOP","Amer, Amer Mustafa R.Ph, MSc","32241695"],"abstract":["Coronaviruses (CoVs) are a large family of viruses that cause disorders ranging from a mild cold to severe disease. Some of the CoVs are zoonotic, meaning they can be transmitted from animals to humans. In December 2019, the world awoke to a new zoonotic strain of CoV that was named SARS-CoV-2 (standing for severe acute respiratory syndrome coronavirus 2), which has been classified as a high-consequence infectious disease. In addition, serious complications related to COVID-19 have been reported in some patients. These include acute respiratory distress syndrome, acute renal failure, septic shock and ventilator-associated pneumonia. The pharmacist, as a healthcare practitioner, can play an important role in hindering the spread of COVID-19, and can be an active participant in national and community efforts to fight and contain this outbreak."],"journal":"Res Social Adm Pharm","authors":["Al-Quteimat, Osama M MSc, BCOP","Amer, Amer Mustafa R.Ph, MSc"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241695","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.sapharm.2020.03.018","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663079112852373504,"score":40.60131}]}